Sunday - December 22, 2024
UT-MD Anderson Cancer Center: Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL
November 28, 2024
HOUSTON, Texas, Nov. 28 (TNSres) -- The University of Texas MD Anderson Cancer Center issued the following news release:

* * *

Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL

Trial results supported recent FDA approval for patients with relapsed/refractory disease

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the nov . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products